Becton Dickinson & Co(BDX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:09 PM ET (Korea 10/27 05:09)
Full metrics table
| Index | S&P 500 | P/E | 59.24 | EPS (ttm) | 3.32 | Insider Own | 0.2% | Shs Outstand | 272.4M | Perf Week | 2.96% |
| Market Cap | 53.49B | Forward P/E | 14.83 | EPS next Y | 4.53% | Insider Trans | -2.17% | Shs Float | 271.8M | Perf Month | 6.84% |
| Enterprise Value | 69.44B | PEG | 1.91 | EPS next Q | 4.07 | Inst Own | 99.79% | Short Float | 3.6% | Perf Quarter | 18.07% |
| Income | 0.94B | P/S | 2.57 | EPS this Y | 11.98% | Inst Trans | -1.7% | Short Ratio | 5.61 | Perf Half Y | 30.73% |
| Sales | 20.84B | P/B | 2.19 | EPS next 5Y | 7.76% | ROA | 2.44% | Short Interest | 9.78M | Perf YTD | 28.77% |
| Book/sh | 89.64 | P/C | 61.92 | EPS past 3/5Y | -0.35% 16.45% | ROE | 5.17% | 52W High | -2.04% ($200.47) | Perf Year | 34.48% |
| Cash/sh | 3.17 | P/FCF | 21.12 | Sales past 3/5Y | 4.99% 6.32% | ROIC | 2.48% | 52W Low | 53.99% ($127.54) | Perf 3Y | -1.68% |
| Dividend Est. | $4.02 (2.05%) | EV/EBITDA | 13.22 | EPS Y/Y TTM | -40.38% | Gross Margin | 46.44% | Volatility(W/M) | 1.78% 2.15% | Perf 5Y | 4.05% |
| Dividend TTM | 3.98 | EV/Sales | 3.33 | Sales Y/Y TTM | -2.56% | Oper. Margin | 14.54% | ATR (14) | 4.11 | Perf 10Y | 52.99% |
| Dividend Ex-Date | 2026/9/9 | Quick Ratio | 0.51 | EPS Q/Q | -31.44% | Profit Margin | 4.52% | RSI (14) | 63.54 | Recom | 2.21 |
| Dividend Gr. 3/5Y | 6.13% 5.65% | Current Ratio | 0.87 | Sales Q/Q | -9.55% | SMA20 | 4.78% ($187.43) | Beta | 0.23 | Target Price | $193.31 |
| Payout | 71.53% | Debt/Eq | 0.69 | Earnings | 2026/11/5 | SMA50 | 5.8% ($185.62) | Rel Volume | 0.94 | Prev Close | $198.91 |
| Employees | 72000 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 2.82% 1.96% | SMA200 | 18.85% ($165.24) | Avg Volume(3M) | 1.74M | Price | $196.39 |
| IPO | 1963/9/25 | Option/Short | Yes/Yes | Trades | 20356 | Volume | 1,640,116 | Change | -1.27% |
💉 This is a US-based large-cap medical device company that supplies medical syringes, diagnostic equipment, and life science instruments. Founded in 1897 and headquartered in New Jersey, it holds a globally leading position in drug delivery, specimen collection, and clinical diagnostics, and is a healthcare stock with a steady track record of dividend increases.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded about as much as usual. That is 94% of its average volume.
Next earnings report: November 5
10 days to go.
BDX earns moderately but has a weak balance sheet
Of every $100 in sales, $14.54 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.0% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,322. Peers typically go for $1,611. Compared with its own 5-year average, it is 41% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +4.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 2.05% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 99.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 51 in the industry
Based on market cap of $53B.
BDX#2 Becton Dickinson & Co $53B PER 59.2 
RMD#3 Resmed Inc $36B PER 24.3 
ALC#4 Alcon Inc $34B PER 53.7 
MDLN#5 Medline Inc $30B PER 39.5 
WST#6 West Pharmaceutical Services Inc $28B PER 50.5 
FAQ
What kind of company is BDX?
BDX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of BDX?
The market cap of BDX is approximately $53.5B, ranking 304 within its sector.
Does BDX pay dividends?
BDX has a dividend yield of approximately 2.05%, with an annual dividend of $4.02.
What is the P/E ratio of BDX?
BDX has a P/E ratio of approximately 59.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BDX?
BDX has recorded a 52-week high of $200.47 and a low of $127.54.
